info@accelevir.com
Start Your Project
About Us
Team
Collaborators
Services
Clinical Solutions
COVID-19 Testing
Infectious Disease
Comparator Testing
Industry Partnering Solutions
Clinical and Discovery Research
Clinical Trials
Companion Diagnostic Partnering
Technologies
Digital PCR & Specialty HIV-1 Persistence Assays
Immuno-oncology Servicess
Cell & Gene Therapy
Specialty Virology Services
Next-Generation Sequencing
Comparator Testing
Academic & Non-Profit
News Room
Recent News
Publications
Academic & Non-Profit
Support for HIV persistence and cure research
Accelevir has established a centralized specialty testing resource – supported by a cooperative agreement with the National Institute of Allergy and Infectious Diseases (NIAID U24AI143502).
Under this program Accelevir offers a comprehensive suite of molecular assays and virology services which include:
IPDA™ HIV-1
IPDA™ SIV
IPDA™ SHIV
Total HIV-1 DNA qPCR
HIV-1 Cell-associated RNA PCR
QVOA (Quantitative Viral Outgrowth Assay) HIV-1
Bulk Outgrowth HIV-1
SCA (Single Copy Assay) HIV-1
HIV-1 Viral Load
Automated cell isolation (RoboSep™ by Stemcell Technologies)
Contact our team to learn how Accelevir can support HIV-1 clinical trials.
Accelevir | © 2023